Renal function and risk of hip and vertebral fractures in older women.

PubWeight™: 3.27‹?› | Rank: Top 1%

🔗 View Article (PMID 17242313)

Published in Arch Intern Med on January 22, 2007

Authors

Kristine E Ensrud1, Li-Ying Lui, Brent C Taylor, Areef Ishani, Michael G Shlipak, Katie L Stone, Jane A Cauley, Sophie A Jamal, Diana M Antoniucci, Steven R Cummings, Osteoporotic Fractures Research Group

Author Affiliations

1: Center for Chronic Disease Outcomes Research, VA Medical Center, Minneapolis, MN 55417, USA. ensru001@umn.edu

Articles citing this

Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med (2008) 2.44

A multi-marker approach to predict incident CKD and microalbuminuria. J Am Soc Nephrol (2010) 1.95

A prospective study of frailty in nephrology-referred patients with CKD. Am J Kidney Dis (2012) 1.90

Lower urinary connective tissue growth factor levels and incident CKD stage 3 in the general population. Am J Kidney Dis (2011) 1.88

Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease. Kidney Int (2012) 1.86

Chronic kidney disease and bone fracture: a growing concern. Kidney Int (2008) 1.76

Cystatin C and risk of hip fractures in older women. J Bone Miner Res (2013) 1.54

Hypovitaminosis D in chronic kidney disease. Clin J Am Soc Nephrol (2008) 1.50

Fracture Burden and Risk Factors in Childhood CKD: Results from the CKiD Cohort Study. J Am Soc Nephrol (2015) 1.47

Pentosidine and increased fracture risk in older adults with type 2 diabetes. J Clin Endocrinol Metab (2009) 1.38

Bone mass and microarchitecture in CKD patients with fracture. J Am Soc Nephrol (2010) 1.26

Cystatin-C, renal function, and incidence of hip fracture in postmenopausal women. J Am Geriatr Soc (2008) 1.24

Renal function and rate of hip bone loss in older men: the Osteoporotic Fractures in Men Study. Osteoporos Int (2008) 1.20

Dietary acid load: a novel nutritional target in chronic kidney disease? Adv Chronic Kidney Dis (2013) 1.15

Serum phosphorus predicts incident chronic kidney disease and end-stage renal disease. Nephrol Dial Transplant (2011) 1.14

Peripheral arterial disease is associated with higher rates of hip bone loss and increased fracture risk in older men. Circulation (2009) 1.14

The effect of raloxifene treatment in postmenopausal women with CKD. J Am Soc Nephrol (2008) 1.13

Mineral metabolism markers and the long-term risk of hip fracture: the cardiovascular health study. J Clin Endocrinol Metab (2011) 1.12

Association of cystatin C with adverse outcomes. Curr Opin Nephrol Hypertens (2009) 1.11

Elevated galectin-3 precedes the development of CKD. J Am Soc Nephrol (2013) 1.06

Inflammatory markers and the risk of hip fracture: the Women's Health Initiative. J Bone Miner Res (2012) 1.05

Low bone mineral density and fractures in stages 3-5 CKD: an updated systematic review and meta-analysis. Osteoporos Int (2014) 1.03

Secondary contributors to bone loss in osteoporosis related hip fractures. Osteoporos Int (2008) 0.99

Fracture risk assessment in patients with chronic kidney disease. Osteoporos Int (2011) 0.99

A comparison of calcium to zoledronic acid for improvement of cortical bone in an animal model of CKD. J Bone Miner Res (2014) 0.98

Bone mineral density by DXA and HR pQCT can discriminate fracture status in men and women with stages 3 to 5 chronic kidney disease. Osteoporos Int (2012) 0.98

Performance of a genetic risk score for CKD stage 3 in the general population. Am J Kidney Dis (2011) 0.96

Alterations of bone microstructure and strength in end-stage renal failure. Osteoporos Int (2012) 0.92

Renal function and nonvertebral fracture risk in multiethnic women: the Women's Health Initiative (WHI). Osteoporos Int (2011) 0.92

Estimated GFR and risk of hip fracture in older men: comparison of associations using cystatin C and creatinine. Am J Kidney Dis (2013) 0.91

A structural approach to skeletal fragility in chronic kidney disease. Semin Nephrol (2009) 0.90

Use of renin-angiotensin system inhibitors is associated with reduction of fracture risk in hemodialysis patients. PLoS One (2015) 0.90

Evaluating bone quality in patients with chronic kidney disease. Nat Rev Nephrol (2013) 0.88

Challenges in implementing and maintaining osteoporosis therapy. Int J Womens Health (2014) 0.86

The effect of a diet containing 70% protein from plants on mineral metabolism and musculoskeletal health in chronic kidney disease. Am J Nephrol (2015) 0.86

Potential explanatory factors for higher incident hip fracture risk in older diabetic adults. Curr Gerontol Geriatr Res (2011) 0.85

Estimated GFR and fracture risk: a population-based study. Clin J Am Soc Nephrol (2013) 0.84

Changes in skeletal collagen cross-links and matrix hydration in high- and low-turnover chronic kidney disease. Osteoporos Int (2014) 0.84

Serum urate levels and the risk of hip fractures: data from the Cardiovascular Health Study. Metabolism (2014) 0.83

Effect of renal function on skeletal health in primary hyperparathyroidism. J Clin Endocrinol Metab (2012) 0.83

Use of renal function measurements for assessing fracture risk in postmenopausal women. Mayo Clin Proc (2008) 0.82

Comparison of fracture risk prediction among individuals with reduced and normal kidney function. Clin J Am Soc Nephrol (2015) 0.80

Independent from muscle power and balance performance, a creatinine clearance below 65 ml/min is a significant and independent risk factor for falls and fall-related fractures in elderly men and women diagnosed with osteoporosis. Osteoporos Int (2009) 0.80

Alfacalcidol improves muscle power, muscle function and balance in elderly patients with reduced bone mass. Rheumatol Int (2010) 0.80

Chronic kidney disease and the skeleton. Bone Res (2014) 0.79

Fracture risk in CKD. Clin J Am Soc Nephrol (2013) 0.79

Applicability of fibroblast growth factor 23 for evaluation of risk of vertebral fracture and chronic kidney disease-mineral bone disease in elderly chronic kidney disease patients. BMC Nephrol (2012) 0.79

Renal function and risk of hip and vertebral fractures in older women: is it always osteoporosis? Arch Intern Med (2007) 0.78

Response of Bone Resorption Markers to Aristolochia longa Intake by Algerian Breast Cancer Postmenopausal Women. Adv Pharmacol Sci (2014) 0.78

Trabecular Bone Score and Incident Fragility Fracture Risk in Adults with Reduced Kidney Function. Clin J Am Soc Nephrol (2016) 0.78

The Role of Galectin-3 in the Kidneys. Int J Mol Sci (2016) 0.78

Change in estimated glomerular filtration rate and fracture risk in the Action to Control Cardiovascular Risk in Diabetes Trial. Bone (2015) 0.77

Epidemiological study of orthopedic injuries in hemodialysis patients in Taiwan: a fixed cohort survey, 2004-2008. Clin Interv Aging (2013) 0.77

Compromised vertebral structural and mechanical properties associated with progressive kidney disease and the effects of traditional pharmacological interventions. Bone (2015) 0.77

(18)F-fluoride positron emission tomography measurements of regional bone formation in hemodialysis patients with suspected adynamic bone disease. Calcif Tissue Int (2013) 0.76

Molecular Abnormalities Underlying Bone Fragility in Chronic Kidney Disease. Biomed Res Int (2017) 0.75

Association between Nurse Staffing and In-Hospital Bone Fractures: A Retrospective Cohort Study. Health Serv Res (2016) 0.75

Bone marrow fat is increased in chronic kidney disease by magnetic resonance spectroscopy. Osteoporos Int (2015) 0.75

Inhibition of GSK-3β increases trabecular bone volume but not cortical bone volume in adenine-induced uremic mice with severe hyperparathyroidism. Physiol Rep (2016) 0.75

Glomerular filtration rate results reflect estimation. Arch Intern Med (2007) 0.75

Cystatin C is Better than Serum Creatinine for Estimating Glomerular Filtration Rate to Detect Osteopenia in Chronic Kidney Disease Patients. Yonsei Med J (2017) 0.75

Safety and effectiveness of daily teriparatide for osteoporosis in patients with severe stages of chronic kidney disease: post hoc analysis of a postmarketing observational study. Clin Interv Aging (2016) 0.75

Decreased cortical thickness, as estimated by a newly developed ultrasound device, as a risk for vertebral fracture in type 2 diabetes mellitus patients with eGFR of less than 60 mL/min/1.73 m2. Osteoporos Int (2014) 0.75

Efficacy and safety of osteoporosis medications in a rat model of late-stage chronic kidney disease accompanied by secondary hyperparathyroidism and hyperphosphatemia. Osteoporos Int (2016) 0.75

Low holotranscobalamin and cobalamins predict incident fractures in elderly men: the MrOS Sweden. Osteoporos Int (2013) 0.75

Articles by these authors

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med (2007) 18.27

Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA (2006) 12.47

Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med (2006) 12.09

Ultrasonography versus computed tomography for suspected nephrolithiasis. N Engl J Med (2014) 11.30

Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet (2010) 8.89

Age and association of kidney measures with mortality and end-stage renal disease. JAMA (2012) 7.20

Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA (2013) 7.19

A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med (2012) 6.85

Effects of Testosterone Treatment in Older Men. N Engl J Med (2016) 6.66

Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial. Lancet (2009) 6.66

Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis (2009) 6.54

2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ (2010) 6.37

Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA (2011) 6.10

Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med (2008) 6.02

Bone-density testing interval and transition to osteoporosis in older women. N Engl J Med (2012) 5.81

New loci associated with kidney function and chronic kidney disease. Nat Genet (2010) 5.58

Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet (2012) 5.48

Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int (2011) 5.47

Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (2003) 5.38

Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis (2010) 5.35

Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women. Arch Intern Med (2008) 5.14

High-trauma fractures and low bone mineral density in older women and men. JAMA (2007) 5.00

The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study. Ann Intern Med (2010) 4.89

Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women. JAMA (2011) 4.83

Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med (2008) 4.81

Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet (2009) 4.78

The relative safety of ephedra compared with other herbal products. Ann Intern Med (2003) 4.65

BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures. J Bone Miner Res (2003) 4.64

Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med (2005) 4.57

Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness. Ann Intern Med (2011) 4.28

Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol (2003) 4.28

The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res (2012) 4.15

Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene. J Natl Cancer Inst (2004) 4.09

Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. JAMA (2003) 4.07

Cystatin C identifies chronic kidney disease patients at higher risk for complications. J Am Soc Nephrol (2010) 3.85

Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol (2006) 3.85

American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. J Clin Oncol (2003) 3.71

Rapid kidney function decline and mortality risk in older adults. Arch Intern Med (2008) 3.54

Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative. Arch Intern Med (2010) 3.53

Meta-analysis: effect of patient self-testing and self-management of long-term anticoagulation on major clinical outcomes. Ann Intern Med (2011) 3.53

Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J Am Soc Nephrol (2011) 3.53

Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures. Arch Intern Med (2007) 3.50

Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study. Arch Intern Med (2005) 3.39

A comparison of prediction models for fractures in older women: is more better? Arch Intern Med (2009) 3.37

Validity of self-report for fractures among a multiethnic cohort of postmenopausal women: results from the Women's Health Initiative observational study and clinical trials. Menopause (2004) 3.33

Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation (2006) 3.31

Bone mineral density and the risk of incident nonspinal fractures in black and white women. JAMA (2005) 3.30

Kidney function as a predictor of noncardiovascular mortality. J Am Soc Nephrol (2005) 3.28

Duration of lactation and risk factors for maternal cardiovascular disease. Obstet Gynecol (2009) 3.18

Oral bisphosphonate use and breast cancer incidence in postmenopausal women. J Clin Oncol (2010) 3.17

Frailty and risk of falls, fracture, and mortality in older women: the study of osteoporotic fractures. J Gerontol A Biol Sci Med Sci (2007) 3.16

Thiazolidinedione use and bone loss in older diabetic adults. J Clin Endocrinol Metab (2006) 3.15

Long-term risk of incident vertebral fractures. JAMA (2007) 3.15

Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study. J Am Soc Nephrol (2005) 3.14

A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the Cardiovascular Health Study. Arch Intern Med (2005) 3.14

Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study. AIDS (2009) 3.12

Excerpts from the US Renal Data System 2009 Annual Data Report. Am J Kidney Dis (2010) 3.11

Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes. JAMA (2012) 3.10

A comparison of frailty indexes for the prediction of falls, disability, fractures, and mortality in older men. J Am Geriatr Soc (2009) 3.09

Bone mineral density changes during the menopause transition in a multiethnic cohort of women. J Clin Endocrinol Metab (2007) 3.05

HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr (2012) 2.95

Fetuin-A and incident diabetes mellitus in older persons. JAMA (2008) 2.92

US Renal Data System 2010 Annual Data Report. Am J Kidney Dis (2011) 2.90

Postoperative biomarkers predict acute kidney injury and poor outcomes after pediatric cardiac surgery. J Am Soc Nephrol (2011) 2.90

The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency. Ann Intern Med (2004) 2.86

Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. J Am Coll Cardiol (2003) 2.83

Association of common genetic variation in the insulin/IGF1 signaling pathway with human longevity. Aging Cell (2009) 2.79

Health disparities in endocrine disorders: biological, clinical, and nonclinical factors--an Endocrine Society scientific statement. J Clin Endocrinol Metab (2012) 2.78

Poor sleep is associated with impaired cognitive function in older women: the study of osteoporotic fractures. J Gerontol A Biol Sci Med Sci (2006) 2.73

Older women with diabetes have a higher risk of falls: a prospective study. Diabetes Care (2002) 2.72

Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Intern Med (2007) 2.71

Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons. Circulation (2010) 2.71

CUBN is a gene locus for albuminuria. J Am Soc Nephrol (2011) 2.70

US Renal Data System 2013 Annual Data Report. Am J Kidney Dis (2014) 2.68

Use of alendronate and risk of incident atrial fibrillation in women. Arch Intern Med (2008) 2.66

Serum phosphorus levels associate with coronary atherosclerosis in young adults. J Am Soc Nephrol (2008) 2.65

Association of tenofovir exposure with kidney disease risk in HIV infection. AIDS (2012) 2.65